268 related articles for article (PubMed ID: 16709516)
1. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
Nuamah NM; Goker H; Kilic YA; Dagmoura H; Cakmak A
Haematologica; 2006 May; 91(5 Suppl):ECR08. PubMed ID: 16709516
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
Becker PS; Wagle M; Matous S; Swanson RS; Pihan G; Lowry PA; Stewart FM; Heard SO
Biol Blood Marrow Transplant; 1997 Apr; 3(1):45-9. PubMed ID: 9209740
[TBL] [Abstract][Full Text] [Related]
3. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
4. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
5. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
[TBL] [Abstract][Full Text] [Related]
6. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.
Veerappan R; Morrison M; Williams S; Variakojis D
Bone Marrow Transplant; 2007 Aug; 40(4):361-4. PubMed ID: 17563733
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
Brown SL; Dale DC
Biol Blood Marrow Transplant; 1997 Dec; 3(6):341-3. PubMed ID: 9502302
[No Abstract] [Full Text] [Related]
9. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
Khoury H; Adkins D; Brown R; Vij R; Westervelt P; Trinkaus K; Goodnough LT; DiPersio JF
Bone Marrow Transplant; 2000 Jun; 25(11):1197-201. PubMed ID: 10849533
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support.
Hatzimichael E; Benetatos L; Stebbing J; Kapsali E; Panayiotopoulou S; Bourantas KL
Clin Lab Haematol; 2006 Dec; 28(6):416-8. PubMed ID: 17105496
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
LeBlanc R; Roy J; Demers C; Vu L; Cantin G
Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
[TBL] [Abstract][Full Text] [Related]
12. Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor.
Balaguer H; Galmes A; Ventayol G; Bargay J; Besalduch J
Transfusion; 2004 Aug; 44(8):1260-1. PubMed ID: 15265137
[No Abstract] [Full Text] [Related]
13. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
14. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
16. A rare but severe complication of filgrastim in a healthy donor: splenic rupture.
Akyol G; Pala C; Yildirim A; Keklika M; Demir K; Dortdudak S; Sivgin S; Kaynar L; Esera B; Unal A; Cetin M
Transfus Apher Sci; 2014 Feb; 50(1):53-5. PubMed ID: 24360843
[TBL] [Abstract][Full Text] [Related]
17. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
18. Splenic rupture in a plasma cell leukemia, mobilized with G-CSF for autologous stem cell transplant.
Funes C; Garcia-Candel F; Majado MJ; González-García C; Bas A; Salido E; Moraleda JM; Morales A
J Clin Apher; 2010; 25(4):223-5. PubMed ID: 20818717
[TBL] [Abstract][Full Text] [Related]
19. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
Kroschinsky F; Hölig K; Ehninger G
Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
[TBL] [Abstract][Full Text] [Related]
20. Is a boosting dose of granulocyte-colony-stimulating factor necessary for healthy PBSC donors undergoing secondary apheresis? An institute's experience.
Chen SH; Lu CJ; Wen SH; Zheng YJ; Yang SH; Su YC; Li DK
Transfus Apher Sci; 2009 Apr; 40(2):87-90. PubMed ID: 19233726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
